Biosimilars and Biologics are a relatively new form of medicines that are increasingly being used. They include products like vaccines, insulin to treat diabetes, hormones such as human growth hormone, and many modern medicines used to treat cancer, arthritis and other auto-immune disorders. Replicate a traditional chemical medicine you produce a generic – an expert copy made by companies that didn’t develop the original medicine themselves. You can’t make an exact copy of a biologic medicine because they are made from living things and there is natural variability in all living things, just like two apples are never exactly alike. The generic equivalents of biologics are called ‘biosimilars’. A biosimilar is a highly similar, comparable version of an approved biologic medicine. New biosimilar medicines undergo clinical trials to demonstrate that they work just as well as the approved biologic medicine.
The Journal is using the online System for quality in the peer-review process. Online submission and review system, where authors can submit manuscripts and track their progress. Reviewers can download manuscripts and submit their opinions. Editors can manage the whole submission, review, revise and publish process through the online system. Authors can see the manuscripts are in which stage waiting for publication. A 45 day rapid review process with international peer-review standards and with quality reviewers. The review process is performed by the editorial board members of Biosimilars and Biologics or outside experts, at least two to three independent reviewer’s approval followed by editor approval is required for acceptance of any citable manuscript. After publishing articles are freely available through online without any restrictions or any other subscriptions to researchers worldwide.
Open Access Publishing should be seen as a means of accelerating scientific discovery by providing free and unrestricted access of scientific knowledge via the Internet. An essential role of Open Access is the long-term preservation of peer-reviewed scholarly journal articles and research data. Open Access is not only used for journal articles, but is also being implemented to theses, scholarly monographs, and book chapters. Promotion of Open Access is very crucial to encourage innovation, socioeconomic development, and flow of knowledge around the world. As such, Open Access can be defined as an instrument ultimately used for public welfare to stimulate the growth of global science, as well as maintain the quality of scientific achievements at the same time.
